Eunah Cho

Eunah Cho has a strong background in scientific research and has held various roles throughout their career. Eunah is currently working as a Research Scientist at Cognition Therapeutics, Inc., a position they started in January 2023. Prior to this, they worked at NeuBase Therapeutics, Inc. from March 2021 to January 2022 as a Scientist and from January 2022 to October 2022 as a Scientist II. Before joining NeuBase Therapeutics, Inc., they were a Postdoctoral Associate at Fox Chase Cancer Center from March 2017 to March 2021. Eunah also has experience as a post-doctoral fellow at Thomas Jefferson University from March 2013 to March 2017. Throughout their work experience, Eunah has consistently demonstrated their expertise in scientific research and their ability to contribute to various organizations in the field.

Eunah Cho's education history is as follows:

From 2017 to 2021, Eunah Cho worked as a Postdoctoral Associate at Fox Chase Cancer Center. The field of study during this period is not specified.

Prior to that, from 2013 to 2017, Eunah Cho was a Postdoctoral Fellow at Thomas Jefferson University, specializing in Pathology, Anatomy and Cell Biology.

Eunah Cho obtained a Doctor of Philosophy (PhD) from Seoul National University between 2006 and 2013, with a focus on Biochemistry and Molecular Biology.

Before pursuing a PhD, Eunah Cho earned a Master of Science (MS) degree in Molecular Biology from Chonnam National University from 2003 to 2005.

There is no information available on Eunah Cho's education history at Thomas Jefferson University beyond the fact that they attended the institution.

Additionally, Eunah Cho has obtained several additional certifications. In April 2023, they completed the "Avoiding Insider Trading" certification from Traliant. Furthermore, in March 2023, they completed the "Preventing Discrimination & Harassment: NY Employees Edition V5" certification, also from Traliant.